Subscribe
Magazine
Videos
Advertise
About Us
Smart Water Summit
Wastewater Summit
Drinking Water
Smart Water
Asset Management
Water Utility Management
Water Reuse
Global Thought Leaders
Podcast
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
WaterWorld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Personalis, Inc. - Common Stock
(NQ:
PSNL
)
16.01
+0.13 (+0.82%)
Delayed Quote
Updated: 12:27 PM EDT, Oct 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Personalis, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference
May 14, 2025
From
Personalis, Inc.
Via
Business Wire
Analyst Expectations For Personalis's Future
↗
May 07, 2025
Via
Benzinga
Personalis Reports First Quarter 2025 Financial Results
May 06, 2025
From
Personalis, Inc.
Via
Business Wire
Earnings Scheduled For May 6, 2025
↗
May 06, 2025
Via
Benzinga
Personalis’ NeXT Personal® Detects 100% of Colorectal Cancer Relapses Ahead of Imaging in VICTORI Cancer Study
April 28, 2025
From
Personalis, Inc.
Via
Business Wire
A Glimpse Into The Expert Outlook On Personalis Through 7 Analysts
↗
February 28, 2025
Via
Benzinga
Earnings Scheduled For February 27, 2025
↗
February 27, 2025
Via
Benzinga
Personalis Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
↗
January 27, 2025
Via
Benzinga
Personalis to Announce First Quarter 2025 Financial Results
April 22, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection
April 22, 2025
From
Personalis, Inc.
Via
Business Wire
The Blood Test Revolution: It's A New Day In Cancer. Guardant, Natera And Exact Are Here For It.
↗
April 17, 2025
A revolution in oncology could help cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.
Via
Investor's Business Daily
What 5 Analyst Ratings Have To Say About Personalis
↗
April 10, 2025
Via
Benzinga
Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference
March 26, 2025
From
Personalis, Inc.
Via
Business Wire
This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
March 17, 2025
Via
Benzinga
Cathie Wood-Led Ark Invest Roblox, Roku, UiPath As Markets Take A Dip
↗
March 08, 2025
Ark Invest made significant trades on Friday, selling shares of RBLX, ROKU, PATH and buying shares of IBTA, PSNL, ABSI, and RXRX.
Via
Benzinga
New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection
March 03, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Fourth Quarter and Full Year 2024 Financial Results
February 27, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the TD Cowen's 45th Annual Health Care Conference
February 18, 2025
From
Personalis, Inc.
Via
Business Wire
Goodyear Tire & Rubber Posts Upbeat Results, Joins Nu Skin, Pacific Biosciences of California, Airbnb, Roku And Other Big Stocks Moving Higher On Friday
↗
February 14, 2025
Via
Benzinga
Personalis to Announce Fourth Quarter and Full Year 2024 Financial Results
February 13, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
January 28, 2025
From
Personalis, Inc.
Via
Business Wire
New Nature Medicine Publication Shows ctDNA Levels Linked to Recurrence Risk in Lung Cancer
January 13, 2025
From
Personalis, Inc.
Via
Business Wire
Personalis Reports Preliminary Fourth Quarter and Full Year 2024 Revenue
January 07, 2025
From
Personalis, Inc.
Via
Business Wire
Dow Surges Over 600 Points, Gold Jumps 1.5%
↗
December 20, 2024
Via
Benzinga
Topics
Stocks
Oncology Advancements Accelerate Amid Rising Early-Onset Cancer Diagnoses
December 20, 2024
EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:CRDF),(NASDAQ:PSNL),(NASDAQ:TEM),(NASDAQ:CKPT) EQNX::TICKER_END
Via
FinancialNewsMedia
Topics
Artificial Intelligence
Nasdaq Jumps Over 300 Points, Novo Nordisk Shares Spike Higher
↗
December 20, 2024
Via
Benzinga
Mission Produce, Nvidia, Humacyte, BlackBerry And Other Big Stocks Moving Higher On Friday
↗
December 20, 2024
Via
Benzinga
Stock Of The Day: Where Does The Merck Downtrend End?
↗
December 19, 2024
Shares of Merck & Co (MRK) continue to trend lower. If they reach the $95.00 level, there is a good chance they find support and reverse.
Via
Benzinga
Personalis Advances Business Strategy with Investment from Merck and Extends Collaboration with Moderna
December 19, 2024
From
Personalis, Inc.
Via
Business Wire
Personalis and Tempus Expand Collaboration to Biopharma
December 16, 2024
From
Personalis, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
11
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
